Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.58 USD
-0.21 (-11.48%)
Updated Jun 28, 2024 03:59 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CRLBF 1.58 -0.21(-11.48%)
Will CRLBF be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CRLBF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRLBF
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates
Will Cresco Labs Inc. (CRLBF) Report Negative Earnings Next Week? What You Should Know
CRLBF: What are Zacks experts saying now?
Zacks Private Portfolio Services
AdaptHealth Corp. (AHCO) Lags Q1 Earnings Estimates
Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings
Investors Heavily Search Cresco Labs Inc. (CRLBF): Here is What You Need to Know
Other News for CRLBF
Bearish Friday For Marijuana Stocks - Global Compliance, 1933 Industries Among Top Gainers
Fake Cannabis Unions And A Legal Battle Over Labor Practices In California
Cannabis Stock Gainers And Losers From June 27, 2024
Hospitalizations due to cannabis use on the rise in the U.S. - report
Bullish Wednesday For Marijuana Stocks - Affinor Growers, Blueberries Medical Among Top Gainers